DE2615654C3 - Salbenpräparat zur Intensivierung des WoIl- und Haarwachstums - Google Patents
Salbenpräparat zur Intensivierung des WoIl- und HaarwachstumsInfo
- Publication number
- DE2615654C3 DE2615654C3 DE19762615654 DE2615654A DE2615654C3 DE 2615654 C3 DE2615654 C3 DE 2615654C3 DE 19762615654 DE19762615654 DE 19762615654 DE 2615654 A DE2615654 A DE 2615654A DE 2615654 C3 DE2615654 C3 DE 2615654C3
- Authority
- DE
- Germany
- Prior art keywords
- hair
- wool
- preparation
- hair growth
- ointment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000002360 preparation method Methods 0.000 title claims description 31
- 239000002674 ointment Substances 0.000 title claims description 14
- 210000002268 wool Anatomy 0.000 title claims description 12
- 230000003779 hair growth Effects 0.000 title claims description 11
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 claims description 4
- 201000004384 Alopecia Diseases 0.000 description 23
- 238000011282 treatment Methods 0.000 description 18
- 210000004209 hair Anatomy 0.000 description 17
- 231100000360 alopecia Toxicity 0.000 description 15
- 241001465754 Metazoa Species 0.000 description 11
- 230000003676 hair loss Effects 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 208000024963 hair loss Diseases 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 239000005556 hormone Substances 0.000 description 5
- 229940088597 hormone Drugs 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- -1 1-chloromethyl Chemical group 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- 206010039792 Seborrhoea Diseases 0.000 description 4
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 4
- 230000003698 anagen phase Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000003128 head Anatomy 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 208000008742 seborrheic dermatitis Diseases 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 206010020565 Hyperaemia Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 239000003098 androgen Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000003163 gonadal steroid hormone Substances 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 201000005935 monilethrix Diseases 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- 241000700198 Cavia Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000282339 Mustela Species 0.000 description 2
- 241000772415 Neovison vison Species 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 229940030486 androgens Drugs 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- FPOSCXQHGOVVPD-UHFFFAOYSA-N chloromethyl(trimethoxy)silane Chemical compound CO[Si](CCl)(OC)OC FPOSCXQHGOVVPD-UHFFFAOYSA-N 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 208000000718 duodenal ulcer Diseases 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000001794 hormone therapy Methods 0.000 description 2
- 230000000622 irritating effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000037311 normal skin Effects 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 239000000583 progesterone congener Substances 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 239000003270 steroid hormone Substances 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 229960003604 testosterone Drugs 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000156961 Coenonympha Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 208000014311 Cushing syndrome Diseases 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010048462 Growth of eyelashes Diseases 0.000 description 1
- 208000025309 Hair disease Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241000721454 Pemphigus Species 0.000 description 1
- 241000644027 Perideridia lemmonii Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 206010047486 Virilism Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000036621 balding Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000003778 catagen phase Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 229960003750 ethyl chloride Drugs 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 230000026781 habituation Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 150000003961 organosilicon compounds Chemical class 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 201000009395 primary hyperaldosteronism Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 201000004193 respiratory failure Diseases 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000003797 telogen phase Effects 0.000 description 1
- 230000002277 temperature effect Effects 0.000 description 1
- 230000003390 teratogenic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K8/585—Organosilicon compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19762615654 DE2615654C3 (de) | 1976-04-09 | 1976-04-09 | Salbenpräparat zur Intensivierung des WoIl- und Haarwachstums |
| GB1559476A GB1503095A (en) | 1976-04-09 | 1976-04-15 | Process for stimulating wool and hair growth |
| FR7612285A FR2371199A1 (fr) | 1976-04-09 | 1976-04-26 | Medicament destine a intensifier la croissance du poil et des cheveux |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19762615654 DE2615654C3 (de) | 1976-04-09 | 1976-04-09 | Salbenpräparat zur Intensivierung des WoIl- und Haarwachstums |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DE2615654A1 DE2615654A1 (de) | 1977-10-13 |
| DE2615654B2 DE2615654B2 (de) | 1980-03-13 |
| DE2615654C3 true DE2615654C3 (de) | 1980-10-30 |
Family
ID=5975003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19762615654 Expired DE2615654C3 (de) | 1976-04-09 | 1976-04-09 | Salbenpräparat zur Intensivierung des WoIl- und Haarwachstums |
Country Status (3)
| Country | Link |
|---|---|
| DE (1) | DE2615654C3 (enExample) |
| FR (1) | FR2371199A1 (enExample) |
| GB (1) | GB1503095A (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19534201A1 (de) * | 1995-09-15 | 1997-03-20 | Lohmann Therapie Syst Lts | Zubereitung zur Prophylaxe und/oder Behandlung von Woll- und Haarausfall |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4423041A (en) * | 1979-06-25 | 1983-12-27 | Johnson & Johnson Products, Inc. | Detackifying compositions |
| US4889845A (en) * | 1986-06-09 | 1989-12-26 | American Cyanamid Company | Vehicle for topical application of pharmaceuticals |
| DE10233963A1 (de) * | 2002-07-25 | 2004-02-12 | Itn-Nanovation Gmbh | Verwendung von Silanen in kosmetischen Mitteln und Verfahren zur Haarbehandlung |
-
1976
- 1976-04-09 DE DE19762615654 patent/DE2615654C3/de not_active Expired
- 1976-04-15 GB GB1559476A patent/GB1503095A/en not_active Expired
- 1976-04-26 FR FR7612285A patent/FR2371199A1/fr active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19534201A1 (de) * | 1995-09-15 | 1997-03-20 | Lohmann Therapie Syst Lts | Zubereitung zur Prophylaxe und/oder Behandlung von Woll- und Haarausfall |
Also Published As
| Publication number | Publication date |
|---|---|
| DE2615654A1 (de) | 1977-10-13 |
| GB1503095A (en) | 1978-03-08 |
| FR2371199A1 (fr) | 1978-06-16 |
| DE2615654B2 (de) | 1980-03-13 |
| FR2371199B1 (enExample) | 1979-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3880769T2 (de) | Topische Behandlung von Störungen kranker Haut. | |
| DE3784522T2 (de) | Medizinische zusammensetzungen gegen psoriasis. | |
| DE69830578T2 (de) | Forskolin zur entwicklung magerer körpermasse | |
| DE2841346A1 (de) | Mittel zur behandlung der haut mit antiviraler wirkung | |
| DE1804801C3 (de) | Mittel zur Aknebehandlung | |
| DE2615654C3 (de) | Salbenpräparat zur Intensivierung des WoIl- und Haarwachstums | |
| DE60036639T2 (de) | Verwendung von sumsoo-extrakt in pharmazeutischen verbindungen zur prävention und behandlung erektiler impotenz | |
| DE10221194B4 (de) | Hyaluronidasehaltiges Hautpflegemittel | |
| EP0274104A2 (de) | 13-cis-Retinsäure zur Verwendung in Präparaten gegen alternde Haut | |
| EP0442350B1 (de) | Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung | |
| EP0450123A1 (de) | Diclofenac-Natrium enthaltende pharmazeutische Zusammensetzung zur topischen Anwendung | |
| DE60207034T2 (de) | Pharmazeutische Zusammensetzung zur Behandlung von verfrühter Ejakulation und/oder von Überempfindlichkeit der sexuellen Stimulierung | |
| DE2656602A1 (de) | 2-hydroxymethyl-3,4,5-trihydroxypiperidin, extraktionsverfahren zu seiner herstellung und seine verwendung als arzneimittel | |
| DE2633891C2 (de) | Tris-(hydroxymethyl)-aminomethansalz der 2-(5-Benzoylthienyl)-α-methylessigsäure, Verfahren zu dessen Herstellung und dieses enthaltende pharmazeutische Zusammensetzungen | |
| DE69935350T2 (de) | Verwendung von pyrethroidverbindungen zur förderung des haarwuchses | |
| EP0040604B1 (de) | Kosmetische zubereitung | |
| DE4300969A1 (enExample) | ||
| DE2757024C3 (de) | Kosmetisches Haar- und Hautpflegemittel | |
| EP1131101B1 (de) | Khellin-zubereitung und deren verwendung zur topischen therapie | |
| DE1492023C3 (de) | Hautpflegemittel | |
| DE3519736C2 (de) | Mittel zur Behandlung von Rheuma und Polyarthritis | |
| DE3781662T2 (de) | Wundheilende arzneimittel und kosmetika. | |
| DE1918907C3 (de) | Antiseborrhoeisches Mittel | |
| CH492593A (de) | Hautpflegemittel | |
| DE2749960B2 (de) | Verwendung von Benzylalkohol zur Herstellung reaktivierender kosmetischer Präparate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C3 | Grant after two publication steps (3rd publication) | ||
| 8328 | Change in the person/name/address of the agent |
Free format text: VON FUENER, A., DIPL.-CHEM. DR.RER.NAT. EBBINGHAUS, D., DIPL.-ING., PAT.-ANW., 8000 MUENCHEN |
|
| 8339 | Ceased/non-payment of the annual fee |